Donald Trump Jr. has joined billionaire entrepreneur Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren (D-Mass.)’s strategy to healthcare pricing.
Regardless of their political variations, Trump Jr. and Cuban discovered a typical level of competition in Warren’s healthcare pricing technique. They criticized the senator for not addressing the function of pharmacy profit managers (PBMs) in escalating drug prices.
Warren had beforehand argued that the tax system was “rigged” as a result of giant pharmaceutical firms like Johnson & Johnson JNJ usually escape federal taxes whereas charging exorbitant costs for his or her medicine.
She wrote on X saying that the “highest drug costs within the WORLD whereas usually paying ZERO {dollars} in federal taxes themselves.”
Cuban countered this by stating that PBMs, not pharmaceutical firms, are those controlling and manipulating drug pricing.
Additionally Learn: Cuban on Musk: ‘I Have No Drawback Throwing Elon Beneath the Bus, however I’ll Save It for When It’s Actually Deserved’
Trump Jr. publicly supported Cuban’s viewpoint on X, regardless of Cuban’s well-known opposition to President Trump. This sudden settlement highlights the rising concern over the function of PBMs in healthcare pricing.
PBMs have been dealing with growing scrutiny from federal regulators and lawmakers as a result of their affect on healthcare pricing.
In 2020, the Federal Commerce Fee launched a report criticizing PBMs for imposing unfair phrases on impartial pharmacies, thereby favoring giant company pharmacies like CVS CVS.
The general public criticism from Trump Jr. and Cuban underscores the rising debate over the function of PBMs in healthcare pricing.
Warren’s deal with pharmaceutical firms, whereas not solely misplaced, overlooks the numerous affect of PBMs in figuring out drug costs.
The Federal Commerce Fee’s report from final 12 months additional highlights the necessity for regulatory scrutiny of PBMs. As the controversy continues, it stays to be seen how lawmakers will handle the problem of healthcare pricing and the function of PBMs sooner or later.
Learn Subsequent
Mark Cuban Reacts to Elon Musk-Donald Trump Feud
Picture: Shutterstock/lev radin
